Early sequential changes in serum markers of acute pancreatitis induced by endoscopic retrograde cholangiopancreatography

Pancreatology

Volumn 5, Issue 2-3, 2005, Pages 157-164

  Lempinen, Marko ^a   Stenman, Ulf Håkan ^a   Halttunen, Jorma ^a   Puolakkainen, Pauli ^a   Haapiainen, Reijo ^a   Kemppainen, Esko ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Acute pancreatitis; Endoscopic retrograde cholangiopancreatography; Pancreatic secretory trypsin inhibitor; Trypsinogen

Indexed keywords

APROTININ; BIOLOGICAL MARKER; TRYPSIN; TRYPSIN 2 ALPHA 1 ANTITRYPSIN COMPLEX; TRYPSINOGEN; TRYPSINOGEN 1; TRYPSINOGEN 2; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FLUOROMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN CONTENT; RANDOMIZATION; REACTION TIME; SAMPLE SIZE; STATISTICAL SIGNIFICANCE;

EID: 19944419811     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000085267     Document Type: Article

References (37)

1. Gloor B, Müller CA, Worni M, Martignoni ME, Uhl W, Büchler MW: Late mortality in patients with severe acute pancreatitis. Br J Surg 2001;88:975-979.
2. Tsiotos GG, Luque-de Leon E, Soreide JA, Bannon MP, Zietlow SP, Baerga-Varela Y, Sarr M: Management of necrotizing pancreatitis by repeated operative necrosectomy using a zipper technique. Am J Surg 1998;175:91-98.
3. Steer ML: Frank Brooks Memorial Lecture: The early intraacinar cell events which occur during acute pancreatitis. Pancreas 1998;17: 31-37.
4. Hietaranta AJ, Saluja AK, Bhagat L, Singh VP, Song AM, Steer ML: Relationship between NF-kappaB and trypsinogen activation in rat pancreas after supramaximal caerulein stimulation. Biochem Biophys Res Commun 2001; 280:388-395.
5. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145.
6. Marshall JB: Acute pancreatitis. A review with an emphasis on new developments. Arch Intern Med 1993;153:1185-1198.
7. Figarella C, Negri GA, Guy O: The two human trypsinogens. Inhibition spectra of the two human trypsins derived from their purified zymogens. Eur J Biochem 1975;53:457-463.
8. Kassell B, Kay J: Zymogens of proteolytic enzymes. Science 1973;180:1022-1027.
9. Sainio V, Puolakkainen P, Kemppainen E, Hedström J, Haapiainen R, Kivisaari L, Stenman UH, Schröder T, Kivilaakso E: Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis. Scand J Gastroenterol 1996;31:818-824.
10. Kemppainen E, Mayer J, Puolakkainen P, Raraty M, Slavin J, Neoptolemos JP: Plasma trypsinogen activation peptide in patients with acute pancreatitis. Br J Surg 2001;88:679-680.
11. Pfützer RH, Barmada MM, Brunskill AP, Finch R, Hart PS, Neoptolemos J, Furey WF, Whitcomb DC: SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-623.
12. Stenman UH: Tumor-associated trypsin inhibitor. Clin Chem 2002;48:1206-1209.
13. Ogawa M: Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin Biochem 1988;21:19-25.
14. Borgström A, Ohlsson K: Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe Seylers Z Physiol Chem 1978;359:677-681.
15. Hedström J, Leinonen J, Sainio V, Stenman UH: Time-resolved immunofluorometric assay of trypsin-2 complexed with alpha 1-antitrypsin in serum. Clin Chem 1994;40:1761-1765.
16. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM: Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335: 909-918.
17. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A: Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
18. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, Crosta C, Comin U, Fertitta A, Prada A, Passoni GR, Testoni PA: Complications of diagnostic and therapeutic ERCP: A prospective multicenter study. Am J Gastroenterol 2001;96:417-423.
19. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP: Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointest Endosc 2001;54:425-434.
20. Kemppainen E, Hedström J, Puolakkainen P, Halttunen J, Sainio V, Haapiainen R, Kivilaakso E, Stenman UH: Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy. Gut 1997;41:690-695.
21. Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11-13, 1992. Arch Surg 1993;128:586-590.
22. Campbell MJ, Machin D: Medical Statistics: A Commonsense Approach, ed 3. New York, Wiley, 1999.
23. Itkonen O, Koivunen E, Hurme M, Alfthan H, Schröder T, Stenman UH: Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med 1990;115:712-718.
24. Hedström J, Haglund C, Kemppainen E, Leinimaa M, Leinonen J, Stenman UH: Time-resolved immunofluorometric assay of trypsin-1 complexed with alpha(1)-antitrypsin in serum: Increased immunoreactivity in patients with biliary tract cancer. Clin Chem 1999;45: 1768-1773.
25. Osman S, Turpeinen U, Itkonen O, Stenman UH: Optimization of a time-resolved immunofluorometric assay for tumor-associated trypsin inhibitor (TATI) using the streptavidin-biotin system. J Immunol Methods 1993;161: 97-106.
26. Colomb E, Figarella C, Guy O: The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity. Biochim Biophys Acta 1979;570: 397-405.
27. Cook LJ, Musa OA, Case RM: Intracellular transport of pancreatic enzymes. Scand J Gastroenterol Suppl 1996;219:1-5.
28. Eddeland A, Ohlsson K: Studies on the pancreatic secretory trypsin inhibitor in plasma and its complex with trypsin in vivo and in vitro. Scand J Clin Lab Invest 1978;38:507-515.
29. Ogawa M, Kitahara T, Fujimoto K, Tanaka S, Takatsuka Y, Kosaki G: Serum pancreatic secretory trypsin inhibitor in acute pancreatitis. Lancet 1980;ii:205.
30. Pezzilli R, Billi P, Plate L, Barakat B, Bongiovanni F, Miglioli M: Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol 1994;19:112-117.
31. Lasson A, Borgström A, Ohlsson K: Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures. Scand J Gastroenterol 1986;21:1275-1280.
32. Yasuda T, Ohmachi Y, Katsuki M, Yokoyama M, Murata A, Monden M, Matsubara K: Identification of novel pancreas-specific regulatory sequences in the promoter region of human pancreatic secretory trypsin inhibitor gene. J Biol Chem 1998;273:34413-34421.
33. Hedström J, Sainio V, Kemppainen E, Puolakkainen P, Haapiainen R, Kivilaakso E, Schauman KO, Stenman UH: Urine trypsinogen-2 as marker of acute pancreatitis. Clin Chem 1996;42:685-690.
34. Puolakkainen P, Valtonen V, Paananen A, Schröder T: C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut 1987;28: 764-771.
35. 5 Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkainen PA: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study. Lancet 2000;355:1955-1960.
36. Sultan S, Baillie J: What are the predictors of post-ERCP pancreatitis, and how useful are they? JOP 2002;3:188-194.
37. Gottlieb K, Sherman S: ERCP and biliary endoscopic sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 1998;8: 87-114.